Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Michael Chen, CEO and co-founder, Nuclera
    11 May 2026

    Nuclera launches antibody triage service to advance AI-driven antibody discovery

    Rapid binder triage, of AI-driven candidate sets, enables early elimination of non-binders ahead of costly downstream workflowsPowered by cell-free technology to convert AI-generated candidates into experimental binding dataCambridge, UK and Boston MA, USA, 11 May 2026: Nuclera, the bio...

    Isopod
    11 May 2026

    Guardtech unveil revamped Isopod Configurator online cleanroom pod builder tool

    The East Anglian cleanroom construction specialists have given their revolutionary ‘build your own cleanroom’ software a facelift to further enhance users’ procurement journey ...

    NualaMcBride.jpg
    7 May 2026

    Nuala McBride joins Salus Wellness

    Nuala McBride is a degree-qualified nutritionist registered under the UK's Association for Nutrition. ...

    Presentation slide of Management and resolution of Challenging Behaviours after Acquired Brain Injury
    7 May 2026

    Clement Mind presents at UKABIF 2026: Managing Challenging Behaviours after Acquired Brain Injury

    Dr Alberto Bonilla Miralles, Clinical & Occupational Psychologist and Director at Clement Mind, delivered a specialist presentation at the UK Acquired Brain Injury Forum (UKABIF) on evidence-based approaches to understanding and managing challenging behaviours following an acquired ...

    Calla Lily Clinical Care’s Callavid platform for intravaginal drug delivery
    6 May 2026

    Calla Lily Clinical Care doses first patients in clinical trial for intravaginal drug delivery platform for threatened miscarriage

    FREEDOM study to evaluate progesterone delivery using Callavid intravaginal platformNIHR-funded trial in collaboration with University Hospitals Coventry and Warwickshire NHS TrustLondon, UK, 06 May 2026: Calla Lily Clinical Care, a women’s health-focused medical technology company, ann...

     Brandon Pence, president and chief operations officer, FUJIFILM Biosciences	 Dr. Lindsay Davies, chief scientific officer, NextCell Pharma AB
    6 May 2026

    FUJIFILM Biosciences and NextCell launch new commercial platform comprised of RUO Stromal Cells and Cell Culture Media

    Collaboration results in platform to help researchers overcome challenges in MSC researchNextCell-Cord RUO cells designed for delivery as cryopreserved and sold as an individual product or bundled with PRIME-XV media from FUJIFILM Biosciences ...

    cyber security, phishing attacks, Ai
    5 May 2026

    Beware the next generation of phishing attacks

    If phishing scams are supposed to trick people, why do so many of them still feel clumsy?For years, the answer was simple: Most scams were mass-produced.The same email, the same fake website, sent to thousands of people, hoping a few would fall for it. ...

    TrailBlazer StarBright Dye Label Kits
    5 May 2026

    Bio-Rad expands range of TrailBlazer Kits for Antibody Conjugation to StarBright Dyes

    Expanded Range Increases Access to Bio-Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research ...

    Why Cambridge UK Remains a Global Hub for Antibody Discovery
    1 July 2025

    Why Cambridge UK remains a global hub for antibody discovery

    Cambridge UK has long been one of the world’s most important centres for life sciences, translational research and biotechnology innovation. For antibody discovery, the cluster offers a powerful combination of scientific expertise, commercial infrastructure, regulatory awareness, invest...

    NGS in Antibody Discovery: Why Sequence Depth Matters
    3 September 2025

    NGS in antibody discovery: Why sequence depth matters

    Next-generation sequencing is changing how antibody discovery teams understand library performance, selection outputs and candidate diversity. Rather than relying only on small numbers of picked clones or traditional sequencing methods, NGS can provide a deeper view of how binders emerg...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 16
    • Page 17
    • Current page 18
    • Page 19
    • Page 20
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS